Procter & Gamble Logo
US7427181091
852062
PG

Procter & Gamble

Chargement des cours...

Prévisions

L'objectif de cours moyen des analystes est de 155,44 € (-1,11 %). La médiane est de 152,65 € (-2,89 %).

Acheter
  30
Conserver
  22
Vendre
  1

Discussions dans la communauté

  • Traduit (original en allemand)

    Une action. 20 ans. Pas de vente.

    Bakterius Bakterius II dans Schnack

    12 41
  • Traduit (original en allemand)

    Gestion des actions de qualité non performantes

    Das_Lama Das_Lama III dans Schnack

    8 55
  • Gewinner laufen lassen/ Schäfchen ins Trockene bringen

    Parqet Nutzer Parqet Nutzer II dans Schnack

    0 8
  • Regelmäßige Dividenden

    Bakterius Bakterius II dans Schnack

    1 61
  • 2 20

  • Procter & Gamble impresses with 70 years of dividend growth and stable revenue

    Procter & Gamble has increased its dividend for 70 consecutive years and has paid uninterrupted dividends for 136 years. In the most recent quarter, revenue rose organically by 4 percent, and operating cash flow was $5.8 billion. In fiscal 2026, more than $10 billion was paid in dividends and around $5 billion went to share buybacks. The stock, with a forward P/E of about 24, is not cheap but—thanks to strong brands and stable cash flows—offers defensive stability compared with volatile tech names. » Plus sur deraktionaer.de


  • Procter & Gamble confirms profit forecast despite sharply higher costs

    In the first fiscal quarter 2026/27, Procter & Gamble’s revenue rose 4.0% to USD 23.28 billion, with organic growth (adjusted) also at 4.0%; adjusted earnings per share climbed to USD 2.00 and beat expectations. The adjusted EBIT margin fell from 26.7% to 25.9% due to significantly higher raw material and transportation costs. Management slightly raised the sales outlook (2–4%), confirmed the adjusted EPS guidance of USD 6.89–7.11, and plans share buybacks and dividend payments of several billion dollars each; at the same time, higher raw material, interest and currency effects weighed on results. » Plus sur finanzen.net


  • Procter & Gamble starts the 2026/27 fiscal year strongly

    The US consumer goods giant Procter & Gamble reported organic sales growth of 4% to $23.3 billion for the three months ended September, driven mainly by volumes with only modestly higher prices. Net income was about $4.7 billion, roughly flat year-on-year, and adjusted earnings per share rose 1% to $2.00. P&G confirmed its full-year targets: adjusted EPS to be flat to +3% ($6.89–$7.11) and organic sales growth of 1–3%; including the acquisition of Thorne, sales are expected to increase 2–4%. The stock rose just over 5% in early trading. » Plus sur finanzen.net


  • Procter & Gamble hits 70th consecutive annual dividend increase amid steady fiscal 2026 results

    Procter & Gamble extended its dividend streak to 70 years and yields nearly 3%, supported by fiscal 2026 revenue of about $87 billion (up 3%) and EPS of $6.62 (up 2%). Moody's upgraded the company's credit outlook to positive, citing sustainable free cash flow and earnings growth. The stock is down roughly 8% year‑over‑year and trades at forward and trailing P/E ratios above 20, suggesting it is not inexpensive despite the reliable payout. » Plus sur finance.yahoo.com


  • Moody’s raises outlook for Procter & Gamble to positive after strong cash flow

    Moody’s has confirmed the ratings for Procter & Gamble and Gillette (Aa3/Prime-1) and has raised the rating outlook from stable to positive. The change is justified by sustained free cash flow, strong earnings growth driven by price increases, innovation and cost reductions, and solid credit metrics (retained cash flow/net debt well above 25%, debt/EBITDA below 2). The acquisition of Thorne for USD 3.8 billion will pro forma temporarily increase the leverage ratio to just above 1.6x, but is expected to decline again through integration, scale effects and cost optimization. Moody’s cites potential upgrades or downgrades depending on market shares, profitability, free cash flow and the company’s financial policy. » Plus sur de.investing.com

En 2026, Procter & Gamble a déjà versé 2,77 € de dividendes. Le dernier versement a eu lieu en août.

Données financières de l'entreprise

Au dernier trimestre, Procter & Gamble a réalisé un chiffre d'affaires de 20,55 Md € et un bénéfice net de 4,18 Md €
(EUR) septembre 2026
YoY
Chiffre d'affaires 20,55 Md 7,72 %
Bénéfice brut 10,24 Md 4,50 %
Bénéfice net 4,18 Md 3,19 %
EBITDA 6,23 Md 4,55 %

Données fondamentales

Indicateur Valeur
Capitalisation boursière
357,6 Md €
Nombre d'actions
2,32 Md
Plus haut/bas sur 52 semaines
155,13 € - 125,05 €
Rendement du dividende
2,39 %
Dividendes TTM
3,68 €
Prochain dividende
0,99 €
Bêta
0,36
Ratio P/E
25,16
Ratio PEG
-6,32
Ratio P/B
7,42
Ratio P/S
4,48

Profil de l'entreprise

The Procter & Gamble Company fournit des produits de grande consommation de marque aux consommateurs en Amérique du Nord et en Amérique latine, en Europe, dans la région Asie-Pacifique, en Grande Chine, en Inde, au Moyen-Orient et en Afrique. Elle exerce ses activités dans cinq segments : Beauté ; Soins de la barbe ; Santé ; Soins du linge et de la maison ; et Soins pour bébés, féminins et familiaux. Le segment Beauté propose des après-shampooings, des shampooings, des produits de coiffage et des traitements, ainsi que des antitranspirants et déodorants, des produits de nettoyage corporel et des soins pour la peau, sous les marques Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret et SK-II. The Procter & Gamble Company a été fondée en 1837 et son siège social se trouve à Cincinnati, dans l'Ohio.

Nom
Procter & Gamble
PDG
Shailesh G. Jejurikar
Siège social Cincinnati, oh
États-Unis
Site web
Secteur
Consommation de base
Industrie
Produits ménagers
Introduction en bourse
02/01/1962
Employés 104 000

Symboles boursiers

Bourse Symbole
NYSE
PG
XETRA
PRG.DE
Frankfurt
PRG.F
Düsseldorf
PRG.DU
Hamburg
PRG.HM
Milan
1PG.MI
London
0NOF.L
SIX
PG.SW
München
PRG.MU
Wien
PG.VI
🍪

Parqet  utilise des cookies. En savoir plus